logo
Boardman High School senior diagnosed with rare condition

Boardman High School senior diagnosed with rare condition

Yahoo21-03-2025
BOARDMAN, Ohio (WKBN) — A Boardman High School senior recently diagnosed with a rare condition is up for the fight after receiving the devasting news.
Kayden Beish has FAP, Familial Adenomatous Polyposis, a genetic mutation in genes that would normally protect against the growth of polyps.
'It's really hard to even think about at my age, especially,' Beish said.
Beish is 18. She's had stomach pain for years but was just diagnosed with FAP last year. She has 100 polyps right now in her GI tract.
'I have good days and bad days, so sometimes I'll have a lot of pain and I can't go to school, I can't go to work or hang out with my friends,' she said.
FAP usually leads to colon cancer. It's not pretty to think about but her Mom believes in her.
'If anybody can handle this, it is Kayden. She perseveres and pushes through and overcomes anything that's thrown at her,' said her mother Katie Fuline.
FAP was a giant diagnosis, words the family had never heard. It's even tougher for a girl during her senior year, looking forward to life. Beish will have to think about surgeries and whether it could lead to something worse.
'And that's our goal, is to just keep up with the testing and keep on top of it, and never let this get to cancer. But you never know,' Fuline said.
Beish is going to Hawaii over spring break. The trip is from Make A Wish. 'Kayden's Krew' bracelets also show the support she's getting from her family and at school to keep her spirits up. And later this month, a spaghetti dinner will raise vital support to help her now and in the future — because there's no cure for FAP.
'I never want there to be a time where she says I can't get testing done, or I can't have a surgery done because I don't have the money available for it,' Fuline said.
FAP is something Kayden will keep fighting.
Kayden's Krew Spaghetti Dinner will be March 30 at the Boardman High School cafeteria from 1-5 p.m. Tickets for those 13 and up cost $12, children 5-12 are $8 and kids under four are free.
In addition, there will be basket raffles and a bake sale. You can even donate cookies or cakes to be sold.
To purchase tickets or donate baskets call Marlene at 330-207-6304 or Heidi at 330-984-5735.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Philadelphia Phillies' Edmundo Sosa surprises cerebral palsy patient from Panama before game
Philadelphia Phillies' Edmundo Sosa surprises cerebral palsy patient from Panama before game

CBS News

time7 days ago

  • CBS News

Philadelphia Phillies' Edmundo Sosa surprises cerebral palsy patient from Panama before game

A young patient from Panama got a special trip to see the Philadelphia Phillies, thanks to the kindness of strangers Dylan Morales, 9, is still feeling the love at the Ronald McDonald House in Camden, New Jersey, the day after meeting his hero, Phillies infielder Edmundo Sosa, a fellow Panamanian. Morales, who is being treated for cerebral palsy, was surprised by Sosa before Sunday's game against the Detroit Tigers, and he got lots of Phillies swag, including a signed jersey. Morales' young life has been filled with challenges and heartbreak as he struggled with the neurological disorder, and then a year ago, his father was killed in a car crash "It's very difficult," Morales' mother, Anna, said. The Make-A-Wish Foundation in Panama arranged for Dylan Morales and his mom to come to Philadelphia for him to have leg surgery at Shriners Hospital. "This country is wonderful for my family," Anna Morales said. "Everyone has been so wonderful to see, and it's nice. Anna Morales said she says she's been filled with gratitude during the visit, thanks to the hospitality of the RMHC, along with the medical expertise at Shriners. And, of course, the unimaginable visit to the Phillies game. "Its good, very good," she said. "Dylan and me [are] very happy." The meeting came together with the help of the Consulate's Office from Panama and a Facebook group. "The community really stepped up," Tamara Balbanan, of the Consulate's Office from Panama, said. "I'm just really happy for them," she added. "I know they've been through a lot. She's a great person, and Dylan is amazing. They deserve this." After the surgery, Dylan Morales was in a wheelchair, and with approval from his doctors, he was happy to give it up. The Phillies now have a new forever fan. Dylan Morales and his mom are expecting to go back to Panama at the end of the month. They say the Phillies and the city will always have a special place in their hearts.

Why Recursion Pharmaceuticals Stock Got Mashed on Monday
Why Recursion Pharmaceuticals Stock Got Mashed on Monday

Yahoo

time30-07-2025

  • Yahoo

Why Recursion Pharmaceuticals Stock Got Mashed on Monday

Key Points The company isn't the only developer of a drug for FAP, a rare genetic disease. A rival just reported that its own FAP treatment is advancing to late-stage testing. 10 stocks we like better than Recursion Pharmaceuticals › Clinical-stage biotech Recursion Pharmaceuticals' (NASDAQ: RXRX) stock took it on the chin in the first trading day of the week. Monday saw investors back out of the company's shares, leaving them with an almost 3% decline at market close. The benchmark S&P 500 (SNPINDEX: ^GSPC) did notably better, ticking up slightly on the day. A rival reports a major step forward This was largely due to news from a rival clincal-stage biotech. Late on Friday, U.K.-based Biodexa announced it had launched a phase 3 clinical trial of its eRapa, an investigational drug that targets familial adenomatous polyposis (FAP). This is a rare genetic disease which, when left untreated, typically leads to colorectal cancer. Biodexa has been granted Fast Track status for investigating the drug from the U.S. Food and Drug Administration (FDA). This followed a phase 2 clinical trial in which the drug met its primary endpoints. The advancement of eRapa puts it ahead of Recursion's REC-4881, which is also aimed at treating FAP. The company completed a phase 1b/2 study of the drug earlier this year. Like Biodexa's drug, REC-4881 did well in that stage of testing. The best should win As any seasoned biotech investor would attest, it's the final results and approval process of a drug that ultimately count. Given that, it's hardly encouraging that Biodexa has taken a big step forward ahead of Recursion in the development of its FAP medication. The latter company's investors will be hoping that REC-4881 ultimately proves to be the more efficacious drug for the disorder. Should you invest $1,000 in Recursion Pharmaceuticals right now? Before you buy stock in Recursion Pharmaceuticals, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Recursion Pharmaceuticals wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $636,628!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,063,471!* Now, it's worth noting Stock Advisor's total average return is 1,041% — a market-crushing outperformance compared to 183% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of July 28, 2025 Eric Volkman has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. Why Recursion Pharmaceuticals Stock Got Mashed on Monday was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

What causes colon cancer? And how do you prevent it?
What causes colon cancer? And how do you prevent it?

USA Today

time16-07-2025

  • USA Today

What causes colon cancer? And how do you prevent it?

Colon cancer is one of the most preventable cancers in the U.S., but each year it claims more than 50,000 lives – in part because early symptoms can be mild and easily missed. 'Colon cancer is the deadliest cancer for men under 50 and second deadliest for women under 50,' says Dr. Heinz-Josef Lenz, professor of medicine at the University of Southern California Keck School of Medicine. The good news is that when it is caught early, colon cancer is highly treatable. Even better, it's largely preventable through routine screening and healthy dietary and lifestyle habits. Here's what colon cancer is, what increases your risk and how you can take steps to prevent it. What is colon cancer? Colon cancer (also sometimes referred to as colorectal cancer because it often spreads to the rectum) is a disease that begins with the formation of benign polyps in the body's large intestine, also known as the colon. Over time, these polyps can become cancerous (malignant) and spread to other areas of the body. Symptoms of more advanced stages of colon cancer usually include "abdominal pain, bloody stool, a change in bowel habits (such as constipation or diarrhea), anemia due to blood loss and unexplained weight loss," explains Dr. Xavier Llor, a gastroenterologist at Yale Medicine, who specializes in colon cancer prevention. "But early on," he says, "symptoms can be mild or even absent.' While individual risk factors vary, the average risk of developing colorectal cancer over one's lifetime is about one in 24 for men and about one in 26 for women, per the American Cancer Society. In case you missed: James Van Der Beek, Jenna Fischer and the rise of young people getting cancer What causes colon cancer? While exact causes can't always be known and vary widely from patient to patient, a family history of colon cancer is known to dramatically increase one's risk, says Llor. Ditto for associated inherited conditions such as Lynch syndrome or familial adenomatous polyposis (FAP). Inflammatory bowel diseases like Crohn's or ulcerative colitis also increase risk due to ongoing inflammation in the digestive tract, explains Lenz, and type 2 diabetes may play a role as well. Age is a factor, too, as most cases of colon cancer occur in individuals over 50, but incidence among younger adults is rising. Many of the most common causes of colon cancer are thought to be related to lifestyle behaviors and dietary choices. "Diets rich in red meat such as beef, and pork – particularly if it's fried or broiled – and eating processed meats such as hot dogs and deli meat have been shown to cause colon cancer," says LLor. A lack of physical activity, obesity, smoking and excessive alcohol consumption can also all contribute, says Lenz. IBD is becoming more common. What exactly causes it? How to prevent colon cancer Understanding how these factors can cause colon cancer goes a long way in helping prevent it. But even more people avoid the worst outcomes of colon cancer by getting screened early and as often as is recommended. Here are the most commonly recommended suggestions that help colon cancer be one of today's most preventable cancers. No matter how you and your doctor choose for you to get screened, what matters is doing so as soon as you reach the recommended age and then keeping up with screenings every five to 10 years, as advised by your doctor. 'If caught early,' Llor says, 'your chances of surviving colon cancer are excellent at around 90%.'

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store